Cite Filings / TCRT / 0001683168-26-007898

Feed Companies Filings Check

Sign in

SCHEDULE 13D

Beneficial Ownership Report

Alaunos Therapeutics, Inc. Filed 2026-10-15 Acc 0001683168-26-007898

Documents 1

SCHEDULE 13D Beneficial Ownership Report , xslSCHEDULE_13D_X02/primary_doc.xml

Around this filing

2026-10-21 8-K Delisting notice
2026-10-15 3 Initial Statement of Ownership
2026-10-15 SCHEDULE 13D Beneficial Ownership Report
2026-10-15 SCHEDULE 13D/A Beneficial Ownership Report
2026-10-13 8-K Material agreement · Acquisition or sale completed · Unregistered share sale · Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure
2026-10-09 8-K Delisting notice
2025-10-30 SCHEDULE 13D Beneficial Ownership Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…